Li Yang

Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial

Xiaoyan Chen, Qi Zhang, Yunhao Chen, 2023, Hepatology International.